AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36184724 — intervention group
Group type: COMPARATOR
Intervention: Control group (no radiographs)
Number of subjects: 15
Study 36184724 — intervention group
Group type: COMPARATOR
Intervention: 2D group (placement with 2D radiographs)
Number of subjects: 15
Study 36184724 — intervention group
Group type: COMPARATOR
Intervention: CBCT group (placement with CBCT)
Number of subjects: 15
Study 34118436 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 9
Study 34118436 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovulatory phase
Number of subjects: 9
Study 32284389 — intervention group
Group type: EXPERIMENTAL
Intervention: SELF course (25-hour course in nutritional counselling)
Number of subjects: 118
Study 32284389 — intervention group
Group type: COMPARATOR
Intervention: Standard medical curriculum (comparison group)
Number of subjects: 118
Study 36306708 — intervention group
Group type: EXPERIMENTAL
Intervention: Just in Time ergonomic teaching (n = 8)
Number of subjects: 14
Study 36306708 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 14
Study 36306708 — intervention group
Group type: EXPERIMENTAL
Intervention: Just in Time ergonomic teaching
Number of subjects: 14
Study 33806189 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed prostheses supported by zygomatic implants (2–4 zygomatic and 2–4 conventional implants)
Number of subjects: 80
Study 33806189 — intervention group
Group type: COMPARATOR
Intervention: All-on-four concept (fixed prostheses on four implants)
Number of subjects: 80
Study 32493256 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare voucher (HcV) model
Number of subjects: 396
Study 32493256 — intervention group
Group type: COMPARATOR
Intervention: Electronic health card (eHC) model
Number of subjects: 396
Study 32493256 — intervention group
Group type: EXPERIMENTAL
Intervention: Both models
Number of subjects: 396
Study 33810585 — intervention group
Group type: EXPERIMENTAL
Intervention: Overexpression of Pto-CPCa in Arabidopsis thaliana
Number of subjects: 1749
Study 33810585 — intervention group
Group type: EXPERIMENTAL
Intervention: Overexpression of PtoWRKY13 in Arabidopsis thaliana
Number of subjects: 1749
Study 33038494 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented medial rectus recession
Number of subjects: 60
Study 33038494 — intervention group
Group type: COMPARATOR
Intervention: Medial rectus recession with posterior scleral fixation
Number of subjects: 60
Study 36107485 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-chemotherapy NLR
Number of subjects: 94
Study 36107485 — intervention group
Group type: EXPERIMENTAL
Intervention: ΔNLR attenuation during NAC
Number of subjects: 94
Study 36107485 — intervention group
Group type: EXPERIMENTAL
Intervention: NLR score = pre-chemotherapy NLR + ΔNLR
Number of subjects: 94
Study 36107485 — intervention group
Group type: EXPERIMENTAL
Intervention: NLR-attenuating anti-Ly6G treatment with gemcitabine/paclitaxel
Number of subjects: 94
Study 36107485 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil-derived IL-1β
Number of subjects: 94
Study 34499667 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D virtual reality environment
Number of subjects: 40
Study 34499667 — intervention group
Group type: COMPARATOR
Intervention: 2D virtual reality environment
Number of subjects: 40
Study 33593774 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based behavioural lifestyle programme with 12 months of access to EBPI about lifestyle factors in MS, combined with a complex behaviour change programme
Number of subjects: 328
Study 33593774 — intervention group
Group type: COMPARATOR
Intervention: Optimised standard care
Number of subjects: 328
Study 32240383 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic distal pancreatectomy (RDP)
Number of subjects: 103
Study 32240383 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic distal pancreatectomy (LDP)
Number of subjects: 103
Study 35639038 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin and irbesartan
Number of subjects: 132
Study 35639038 — intervention group
Group type: COMPARATOR
Intervention: Irbesartan (control)
Number of subjects: 132
Study 34424893 — intervention group
Group type: EXPERIMENTAL
Intervention: Skinning carcasses of livestock that died suddenly
Number of subjects: 68
Study 34424893 — intervention group
Group type: EXPERIMENTAL
Intervention: Butchering carcasses of livestock that died suddenly
Number of subjects: 68
Study 34424893 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrying carcasses of livestock that died suddenly
Number of subjects: 68
Study 32077525 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-gene urine-based molecular test for detecting clinically significant prostate cancer (GG ≥ 2)
Number of subjects: 492
Study 32077525 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-gene urine-based molecular test
Number of subjects: 492
Study 32077525 — intervention group
Group type: COMPARATOR
Intervention: ERSPC and PBCG risk calculators
Number of subjects: 492
Study 33155041 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 30 mL 0.25% bupivacaine
Number of subjects: 60
Study 33155041 — intervention group
Group type: COMPARATOR
Intervention: Sham block with 30 mL saline
Number of subjects: 60
Study 36164194 — intervention group
Group type: EXPERIMENTAL
Intervention: Omidubicel
Number of subjects: 75
Study 36164194 — intervention group
Group type: COMPARATOR
Intervention: Standard UCB
Number of subjects: 75
Study 32682856 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine plus 0.25% bupivacaine
Number of subjects: 102
Study 32682856 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine (control)
Number of subjects: 102
Study 32884045 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Manipulative Therapy (SMT) at the lumbar segment measured as the stiffest
Number of subjects: 132
Study 32884045 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Manipulative Therapy (SMT) at the lumbar segment measured as having the lowest pain threshold
Number of subjects: 132
Study 32884045 — intervention group
Group type: COMPARATOR
Intervention: Spinal Manipulative Therapy (SMT)
Number of subjects: 132
Study 34463164 — intervention group
Group type: EXPERIMENTAL
Intervention: ospemifene 60 mg/day for 3 months
Number of subjects: 100
Study 34463164 — intervention group
Group type: EXPERIMENTAL
Intervention: ospemifene 60 mg/day for 6 months
Number of subjects: 100
Study 36151105 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 25
Study 36151105 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 25
Study 33212239 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-monitoring via electronic medication monitoring and smartphone application plus remote clinician feedback
Number of subjects: 100
Study 33212239 — intervention group
Group type: COMPARATOR
Intervention: Control group without feedback
Number of subjects: 100
Study 33179073 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous neuroablative radiofrequency (CNARF)
Number of subjects: 188
Study 33179073 — intervention group
Group type: COMPARATOR
Intervention: Pulsed neuromodulative radiofrequency (PNMRF)
Number of subjects: 188
Study 32344728 — intervention group
Group type: EXPERIMENTAL
Intervention: Active re-warm-up in hypoxia (AH)
Number of subjects: 10
Study 32344728 — intervention group
Group type: COMPARATOR
Intervention: Rest in normoxia (RN)
Number of subjects: 10
Study 32344728 — intervention group
Group type: COMPARATOR
Intervention: Active re-warm-up in normoxia (AN)
Number of subjects: 10
Study 32344728 — intervention group
Group type: COMPARATOR
Intervention: Passive strategies (RN and RH)
Number of subjects: 10
Study 34368894 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 42
Study 34368894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 32605893 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 76
Study 32605893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 32605893 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib (for EGFR-mutant tumors)
Number of subjects: 76
Study 32605893 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for EGFR-mutant tumors)
Number of subjects: 76
Study 32605893 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib (for EGFR-wild-type tumors)
Number of subjects: 76
Study 32605893 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for EGFR-wild-type tumors)
Number of subjects: 76
Study 32605893 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 76
Study 32605893 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 76
Study 34166539 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully guided (FG) implant surgery
Number of subjects: 25
Study 34166539 — intervention group
Group type: COMPARATOR
Intervention: Conventionally guided (CG) implant surgery
Number of subjects: 25
Study 35667481 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) administration
Number of subjects: 0
Study 35667481 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 0
Study 33588196 — intervention group
Group type: COMPARATOR
Intervention: CCT
Number of subjects: 87
Study 33588196 — intervention group
Group type: EXPERIMENTAL
Intervention: CCT + MSST
Number of subjects: 87
Study 35857100 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 109
Study 35857100 — intervention group
Group type: COMPARATOR
Intervention: Clinical model (using clinical factors only)
Number of subjects: 109
Study 35857100 — intervention group
Group type: COMPARATOR
Intervention: Radiomics nomogram vs non-survival groups
Number of subjects: 109
Study 34090604 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐lactam treatment for 3 days
Number of subjects: 0
Study 32402616 — intervention group
Group type: EXPERIMENTAL
Intervention: γ‐tACS
Number of subjects: 30
Study 32402616 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study 34562081 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanuts (28 g/d)
Number of subjects: 50
Study 34562081 — intervention group
Group type: COMPARATOR
Intervention: LFHC snack (whole grain crackers and low-fat cheese)
Number of subjects: 50
Study 35235636 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicortical fixation
Number of subjects: 38
Study 35235636 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicortical fixation
Number of subjects: 38
Study 35235636 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect sinus elevation
Number of subjects: 38
Study 33620405 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (1.5 g), thiamine (100 mg), and hydrocortisone (50 mg) every 6 hours (n=252)
Number of subjects: 501
Study 33620405 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo (n=249)
Number of subjects: 501
Study 34261691 — intervention group
Group type: EXPERIMENTAL
Intervention: Flash glucose monitoring with FreeStyle Libre 2 (FSL2) for 24 weeks
Number of subjects: 180
Study 34261691 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG) for 24 weeks
Number of subjects: 180
Study 34261691 — intervention group
Group type: EXPERIMENTAL
Intervention: FSL2
Number of subjects: 180
Study 34261691 — intervention group
Group type: COMPARATOR
Intervention: SMBG
Number of subjects: 180
Study 32465908 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 follow-up phone calls within 31 days at intervals of 7-10 days
Number of subjects: 41
Study 32465908 — intervention group
Group type: COMPARATOR
Intervention: 1 phone call at the end of the study (control)
Number of subjects: 41
Study 33447948 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth
Number of subjects: 194
Study 33447948 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 194
Study 35477621 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine and Samidorphan (OLZ/SAM)
Number of subjects: 0
Study 33991370 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training in addition to neuromuscular exercise and education (ST+NEMEX-EDU)
Number of subjects: 90
Study 33991370 — intervention group
Group type: COMPARATOR
Intervention: Neuromuscular exercise and education alone (NEMEX-EDU)
Number of subjects: 90
Study 34610422 — intervention group
Group type: EXPERIMENTAL
Intervention: Genicular artery embolization (GAE)
Number of subjects: 21
Study 34610422 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 21
Study 34774089 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 45
Study 34774089 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent negative pressure (INP)
Number of subjects: 45
Study 34774089 — intervention group
Group type: COMPARATOR
Intervention: Sham microcurrent (PT)
Number of subjects: 45
Study 34193407 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 10
Study 34193407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 32228673 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetramethylpyrazine phosphate (TMP)
Number of subjects: 120
Study 36137125 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapeutic agents (specific agents not detailed)
Number of subjects: 755
Study 36137125 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind randomized controlled trials
Number of subjects: 755
Study 36137125 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label randomized trials
Number of subjects: 755
Study 35010984 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of bergamot phytosome® and 100 mg of artichoke leaf standardized dry extract
Number of subjects: 60
Study 35010984 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33068165 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented THA
Number of subjects: 50
Study 33068165 — intervention group
Group type: COMPARATOR
Intervention: Cemented THA
Number of subjects: 50
Study 32964693 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led cognitive behavioral group therapy for recovery of self-esteem (CBGTRS)
Number of subjects: 51
Study 36412399 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 80
Study 36412399 — intervention group
Group type: COMPARATOR
Intervention: 3DCRT
Number of subjects: 80
Study 33247553 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive group (200 Rand shopping voucher at Months 2, 3, and 4)
Number of subjects: 200
Study 33247553 — intervention group
Group type: COMPARATOR
Intervention: Control group (no incentive)
Number of subjects: 200
Study 33247553 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive group
Number of subjects: 200
Study 33247553 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 33247553 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 34053371 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Speed Training (HST)
Number of subjects: 24
Study 34053371 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Resistance Training (TRT)
Number of subjects: 24
Study 32471729 — intervention group
Group type: EXPERIMENTAL
Intervention: Abicipar 2 mg every 8 weeks after 3 initial doses at baseline and weeks 4 and 8 (Q8)
Number of subjects: 1888
Study 32471729 — intervention group
Group type: EXPERIMENTAL
Intervention: Abicipar 2 mg every 12 weeks after 3 initial doses at baseline and weeks 4 and 12 (Q12)
Number of subjects: 1888
Study 32471729 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg every 4 weeks (Q4)
Number of subjects: 1888
Study 36331089 — intervention group
Group type: EXPERIMENTAL
Intervention: Confucian values intervention
Number of subjects: 94
Study 36331089 — intervention group
Group type: EXPERIMENTAL
Intervention: Taoist values intervention
Number of subjects: 94
Study 36331089 — intervention group
Group type: COMPARATOR
Intervention: Natural science intervention
Number of subjects: 94
Study 34999543 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Programme (OEP)
Number of subjects: 498
Study 33627086 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction with an infant for 30 min
Number of subjects: 102
Study 33627086 — intervention group
Group type: COMPARATOR
Intervention: Watching a DVD movie of an infant for 30 min
Number of subjects: 102
Study 32700098 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspension Training (ST)
Number of subjects: 42
Study 32700098 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Resistance Training (TRT)
Number of subjects: 42
Study 32700098 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 42
Study 35156069 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 20 mg/kg biannually for a total of four treatments
Number of subjects: 1200
Study 35156069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study 32576776 — intervention group
Group type: EXPERIMENTAL
Intervention: activC prosthesis
Number of subjects: 0
Study 32576776 — intervention group
Group type: COMPARATOR
Intervention: Bryan disc
Number of subjects: 0
Study 36183193 — intervention group
Group type: EXPERIMENTAL
Intervention: Gochicoa‐Rangel
Number of subjects: 227
Study 36183193 — intervention group
Group type: EXPERIMENTAL
Intervention: Nowowiejska
Number of subjects: 227
Study 36183193 — intervention group
Group type: EXPERIMENTAL
Intervention: Assumapcao
Number of subjects: 227
Study 36183193 — intervention group
Group type: EXPERIMENTAL
Intervention: Amra
Number of subjects: 227
Study 34462286 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg once daily for 40 weeks
Number of subjects: 154
Study 34462286 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone 25 mg once daily for 40 weeks
Number of subjects: 154
Study 34462286 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 154
Study 34462286 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone
Number of subjects: 154
Study 32985372 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive imagery cognitive bias modification (CBM) paradigm involving listening to and imagining brief positive imagery scripts
Number of subjects: 80
Study 32985372 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotionally involved manner of imagining scenarios
Number of subjects: 80
Study 32985372 — intervention group
Group type: COMPARATOR
Intervention: Emotionally detached manner of imagining scenarios
Number of subjects: 80
Study 32985372 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory analyses of vivid imagery and recall testing
Number of subjects: 80
Study 34310072 — intervention group
Group type: EXPERIMENTAL
Intervention: CAET combined with traditional speech and language therapy (SLT)
Number of subjects: 68
Study 34310072 — intervention group
Group type: COMPARATOR
Intervention: Control group (SLT only)
Number of subjects: 68
Study 34310072 — intervention group
Group type: EXPERIMENTAL
Intervention: CAET combined with SLT
Number of subjects: 68
Study 34708112 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing menthol gum prior to exercise
Number of subjects: 0
Study 32791985 — intervention group
Group type: EXPERIMENTAL
Intervention: Xonrid® + SOC
Number of subjects: 80
Study 32791985 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 80
Study 34285006 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium salt substitute intervention
Number of subjects: 0
Study 32437921 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy planning according to INSEMA protocol
Number of subjects: 276
Study 32437921 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation dose in axillary level I
Number of subjects: 276
Study 32437921 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation dose in axillary levels II and III
Number of subjects: 276
Study 32437921 — intervention group
Group type: EXPERIMENTAL
Intervention: Association between incidental radiation dose and obesity
Number of subjects: 276
Study 32437921 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of age, boost application, and fractionation schedule
Number of subjects: 276
Study 35680268 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDUS-Family intervention
Number of subjects: 199
Study 34218880 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-based ECG model
Number of subjects: 2541
Study 34218880 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-lead model (V5)
Number of subjects: 2541
Study 34218880 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-lead (bipolar leads) model
Number of subjects: 2541
Study 32182879 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injections into each masseter muscle
Number of subjects: 30
Study 32182879 — intervention group
Group type: COMPARATOR
Intervention: Saline injections into each masseter muscle (placebo)
Number of subjects: 30
Study 32278278 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure plus placebo (PE+PLB)
Number of subjects: 0
Study 32278278 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline plus enhanced medication management (SERT+EMM)
Number of subjects: 0
Study 32278278 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure plus Sertraline (PE+SERT)
Number of subjects: 0
Study 32278278 — intervention group
Group type: COMPARATOR
Intervention: Combat exposed controls (CC)
Number of subjects: 0
Study 32278278 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion Regulation Task (ERT)
Number of subjects: 0
Study 32278278 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Faces Assessment Task (EFAT)
Number of subjects: 0
Study 36017028 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical therapy combined with VEGF therapy (3 therapies for 1 month/time)
Number of subjects: 170
Study 36017028 — intervention group
Group type: COMPARATOR
Intervention: Control group (2 therapies for 1.5 months/time)
Number of subjects: 170
Study 33450291 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine and cannabis co-use
Number of subjects: 82
Study 33450291 — intervention group
Group type: COMPARATOR
Intervention: Cocaine only
Number of subjects: 82
Study 33450291 — intervention group
Group type: COMPARATOR
Intervention: Drug negative urine
Number of subjects: 82
Study 35614405 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic management
Number of subjects: 315